Familial hypercholesterolemia [NEW TOPIC PAGE]

Main|Search|PHGKB




Last Posted: Mar 28, 2019

---

• How much further do we need to decrease LDL cholesterol levels in heterozygous familial hypercholesterolemia?
  Harada-Shiba Mariko et al. Atherosclerosis 2019 Mar
• Leveraging Implementation Science to Address Health Disparities in Genomic Medicine: Examples from the Field.
  Roberts Megan C et al. Ethnicity & disease 2019 29(Suppl 1) 187-192
• Establishing a familial hypercholesterolaemia register - The first year.
  Tilney Myra et al. Atherosclerosis. Supplements 2019 Mar 3624-27
• Familial hypercholesterolemia in China half a century: A review of published literature.
  Peng Jie et al. Atherosclerosis. Supplements 2019 Mar 3612-18
• Investigating the association between familial hypercholesterolemia and perceived depression.
  Chang Nien-Tzu et al. Atherosclerosis. Supplements 2019 Mar 3631-36
• Variable expression and penetrance in Portuguese families with Familial Hypercholesterolemia with mild phenotype.
  Gaspar I M et al. Atherosclerosis. Supplements 2019 Mar 3628-30
• Getting the Lower List Price for PCSK9 inhibitors
  The FH Foundation, March 18, 2019
• Biology, Genetics and Heart Disease
  The FH Foundation, March 14, 2019
• Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.
  Ellis Katrina L et al. Journal of the American College of Cardiology 2019 Mar 73(9) 1029-1039
• EVALUATION OF TREATMENT EFFICACY IN PATIENTS WITH NON-ALCOHOLIC-STEATOHEPATITIS AND HETEROZYGOTIC FAMILIAL HYPERCHOLESTEROLEMIA.
  Yakimenko ? et al. Georgian medical news 2019 Jan (286) 67-72

more